Pathological grading of regression following neoadjuvant chemoradiation therapy: the clinical need is now
- PMID: 22734005
- DOI: 10.1136/jclinpath-2012-200958
Pathological grading of regression following neoadjuvant chemoradiation therapy: the clinical need is now
Abstract
Neoadjuvant chemoradiotherapy for locally advanced rectal cancer has been shown to decrease rates of local recurrence and more than double the rate of sphincter-preserving surgery. There is now compelling evidence that pathological complete response is an independent predictor of likelihood of local recurrence, distal metastases, disease-free and overall survival in locally advanced rectal cancer following neoadjuvant chemoradiotherapy. Pathological regression grading can therefore guide clinical decisions about salvage surgical strategies, adjuvant therapy and long-term surveillance. No universally recognised regression grading system currently exists for pathologists presented with resected tumour specimens following neoadjuvant chemoradiotherapy. The purpose of this review is to highlight the relevance of accurate tumour regression grading in achieving optimal clinical care for patients with rectal cancer.
Comment in
-
Pathological grading of regression: an International Study Group perspective.J Clin Pathol. 2012 Oct;65(10):865-6. doi: 10.1136/jclinpath-2012-201054. Epub 2012 Aug 2. J Clin Pathol. 2012. PMID: 22859397 No abstract available.
Similar articles
-
Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation.J Clin Pathol. 2012 Aug;65(8):687-92. doi: 10.1136/jclinpath-2012-200786. Epub 2012 May 8. J Clin Pathol. 2012. PMID: 22569540
-
Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer.Dis Colon Rectum. 2013 Nov;56(11):1217-27. doi: 10.1097/DCR.0b013e3182a4b236. Dis Colon Rectum. 2013. PMID: 24104995
-
A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.Ann Surg Oncol. 2008 Dec;15(12):3471-7. doi: 10.1245/s10434-008-0149-y. Epub 2008 Oct 10. Ann Surg Oncol. 2008. PMID: 18846402
-
Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.Colorectal Dis. 2015 Oct;17(10):849-61. doi: 10.1111/codi.13081. Colorectal Dis. 2015. PMID: 26260213 Review.
-
[Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].Orv Hetil. 2006 Oct 22;147(42):2011-20. Orv Hetil. 2006. PMID: 17165600 Review. Hungarian.
Cited by
-
Response to the letter to the editor regarding the manuscript entitled "positron emission tomography with [(18)F]-3'-deoxy-3'fluorothymidine (FLT) as a predictor of outcome in patients with locally advanced resectable rectal cancer: a pilot study".Mol Imaging Biol. 2013 Dec;15(6):786-7. doi: 10.1007/s11307-013-0663-6. Mol Imaging Biol. 2013. PMID: 23813333 No abstract available.
-
Controversies in the pathological assessment of colorectal cancer.World J Gastroenterol. 2014 Aug 7;20(29):9850-61. doi: 10.3748/wjg.v20.i29.9850. World J Gastroenterol. 2014. PMID: 25110416 Free PMC article. Review.
-
MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer.Int J Mol Sci. 2016 Jun 3;17(6):878. doi: 10.3390/ijms17060878. Int J Mol Sci. 2016. PMID: 27271609 Free PMC article.
-
Oxaliplatin plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma in Combination with D2 Gastrectomy: NEO-CLASSIC Study.Oncologist. 2019 Oct;24(10):1311-e989. doi: 10.1634/theoncologist.2019-0416. Epub 2019 Jun 25. Oncologist. 2019. PMID: 31239311 Free PMC article.
-
Reply to the letter "How to standardize the evaluation of tumor regression grading of gastrointestinal cancers after neoadjuvant therapy?" by Dr. Nasierowska-Guttmejer and Dr. Szawlowski, VIAR-D-18-00181.Virchows Arch. 2018 Aug;473(2):257-258. doi: 10.1007/s00428-018-2392-3. Epub 2018 Jun 21. Virchows Arch. 2018. PMID: 29926186 No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
